Home / Inspections / 1318372

FDA Inspection 1318372 — Oklahoma Blood Institute East Central

Oklahoma Blood Institute East Central — FEI 1641495

The FDA completed an inspection of Oklahoma Blood Institute East Central on May 7, 2026 in Ada, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 7, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ada, OK (United States)

Facility

Other inspections at this facility

  • 1113288 (NAI Wed Dec 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1063022 (NAI Fri Aug 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 970700 (NAI Wed Mar 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 868819 (VAI Thu Mar 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 772469 (NAI Wed Mar 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources